Diabetes Care 35:12251231 Russell-Jones D, Cuddihy RM, Hanefeld M et al (2012) Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study
Entre los participantes del estudio de 23andMe, la prdida de peso estimada oscil entre el 6 % y el 20 % del peso inicial, y la probabilidad de nuseas o vmitos vari entre el 5 % y el 78 %, dependiendo de la gentica y otros factores
Large-scale CVOTs have demonstrated that GLP-1 RAs significantly reduce the incidence of MACE, including cardiovascular death, non-fatal MI and non-fatal stroke
But to study this potential synergy effectively, the preparation has to be flawless
Pharmacies that ship the same way in January and July are not adequately protecting your medication